Increased MIB-1 Labeling Index Is Associated with Abducens Nerve Morbidity in Primary Sporadic Petroclival Meningioma Surgery: Beyond Location and Approach.
MIB-1
abducens nerve
petroclival meningioma
retrosigmoid approach
Journal
Current oncology (Toronto, Ont.)
ISSN: 1718-7729
Titre abrégé: Curr Oncol
Pays: Switzerland
ID NLM: 9502503
Informations de publication
Date de publication:
16 07 2022
16 07 2022
Historique:
received:
31
05
2022
revised:
13
07
2022
accepted:
15
07
2022
entrez:
25
7
2022
pubmed:
26
7
2022
medline:
28
7
2022
Statut:
epublish
Résumé
Abducens nerve palsy is a severe dysfunction after petroclival meningioma (PC MNG) surgery. The objective of this investigation was to analyze abducens nerve outcomes in patients who underwent the retrosigmoid approach in relation to the MIB-1 index. Thirty-two patients with primary sporadic PC MNG were retrospectively analyzed. Mean follow-up was 28.0 months. Analysis of the MIB-1 index was performed to evaluate the abducens nerve outcome. An optimal MIB-1 index cut-off value (<4/≥4) in the association with postoperative CN VI palsy was determined by ROC analysis (AUC: 0.74, 95% CI: 0.57−0.92). A new-onset CN VI palsy was present in 7 cases (21.88%) and was significantly associated with an increased MIB-1 index (≥4%, p = 0.025) and a peritumoral edema in the brachium pontis (p = 0.047) which might be caused by the increased growth rate. Tumor volume, cavernous sinus infiltration, auditory canal invasion, and Simpson grading were not associated with new CN VI deficits. Six (85.7%) of the 7 patients with both an increased MIB-1 index (≥4%) and new abducens nerve palsy still had a CN VI deficit at the 12-month follow-up. A peritumoral edema caused by a highly proliferative PC MNG with an elevated MIB-1 index (≥4%) is associated with postoperative abducens nerve deficits.
Identifiants
pubmed: 35877258
pii: curroncol29070398
doi: 10.3390/curroncol29070398
pmc: PMC9325237
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
5026-5041Références
J Neurosurg. 1996 Jan;84(1):20-8
pubmed: 8613831
Cancers (Basel). 2022 Feb 18;14(4):
pubmed: 35205781
World Neurosurg. 2019 May;125:e205-e213
pubmed: 30684722
Acta Neuropathol. 2005 Dec;110(6):537-46
pubmed: 16231158
Acta Radiol Suppl. 1953;104:1-177
pubmed: 13147998
J Korean Neurosurg Soc. 2011 Jan;49(1):26-30
pubmed: 21494359
Cancers (Basel). 2021 Jul 20;13(14):
pubmed: 34298854
Neurochirurgie. 2019 Apr - Jun;65(2-3):55-62
pubmed: 31104846
Am J Clin Pathol. 1998 Jan;109(1):69-74
pubmed: 9426520
Cancer. 2008 Dec 15;113(12):3355-63
pubmed: 18988291
Int J Clin Exp Med. 2015 Oct 15;8(10):18185-90
pubmed: 26770418
Neuro Oncol. 2015 Oct;17 Suppl 4:iv1-iv62
pubmed: 26511214
Lancet Oncol. 2016 Sep;17(9):e383-91
pubmed: 27599143
J Neuroophthalmol. 2022 Mar 1;42(1):e209-e216
pubmed: 34974485
Neurosurgery. 1989 Jan;24(1):12-7
pubmed: 2927589
Brain Tumor Pathol. 2014 Jan;31(1):23-30
pubmed: 23250387
Neuro Oncol. 2021 Nov 2;23(11):1821-1834
pubmed: 34181733
Acta Neurochir (Wien). 2020 Jun;162(6):1249-1257
pubmed: 32100111
Sci Rep. 2020 Mar 13;10(1):4655
pubmed: 32170139
J Neurosurg. 1992 Apr;76(4):588-99
pubmed: 1545251
Diagnostics (Basel). 2022 Mar 30;12(4):
pubmed: 35453901
Front Oncol. 2021 Mar 04;11:653614
pubmed: 33747971
Sci Rep. 2017 Jun 5;7(1):2810
pubmed: 28584266
Neurosurgery. 2020 Nov 16;87(6):1289-1298
pubmed: 32614441
J Neuropathol Exp Neurol. 1993 Nov;52(6):609-18
pubmed: 8229080
Cancer. 1996 Jul 1;78(1):133-43
pubmed: 8646709
Neurol Med Chir (Tokyo). 1989 Nov;29(11):1004-11
pubmed: 2483855
Front Oncol. 2022 Apr 01;12:786909
pubmed: 35433418
J Neurosurg. 2012 Jul;117(1):121-8
pubmed: 22559847
Skull Base. 2010 Sep;20(5):337-42
pubmed: 21358997
Ophthalmology. 1985 May;92(5):676-83
pubmed: 4011142
Medicine (Baltimore). 2020 Feb;99(9):e18644
pubmed: 32118704
Surg Neurol. 1983 Mar;19(3):237-43
pubmed: 6601308
J Neurol Surg B Skull Base. 2016 Feb;77(1):6-13
pubmed: 28035290
Neurol Med Chir (Tokyo). 1996 Jan;36(1):1-6
pubmed: 8786827
Neuro Oncol. 2014 May;16(5):735-47
pubmed: 24536048
Brain Tumor Pathol. 2016 Jan;33(1):13-8
pubmed: 26546480
Neuro Oncol. 2021 Aug 2;23(8):1231-1251
pubmed: 34185076
J Neurosurg. 1997 Oct;87(4):610-4
pubmed: 9322850
Int J Cancer. 1983 Jan 15;31(1):13-20
pubmed: 6339421
Cancer Med. 2019 Jun;8(6):2793-2801
pubmed: 30993844
J Cell Physiol. 2000 Mar;182(3):311-22
pubmed: 10653597
Acta Neurochir (Wien). 2020 May;162(5):1205-1213
pubmed: 32152754
Am J Pathol. 2004 Sep;165(3):753-61
pubmed: 15331400
Clin Neurol Neurosurg. 2010 Apr;112(3):177-82
pubmed: 20056312
Acta Neurochir (Wien). 2010 Jul;152(7):1099-116
pubmed: 20419460